Department of Internal Medicine B, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Rheumatol Int. 2018 Sep;38(9):1743-1749. doi: 10.1007/s00296-018-4107-0. Epub 2018 Jul 18.
It is well established that some rheumatic syndromes (RS) are associated with several hematological malignancies. We aimed to describe the clinical course of patients with hematological malignancies mimicking RS. We studied a series of four patients presenting with apparent RS who were eventually diagnosed with hematological malignancies, and reviewed the relevant literature. Our series consisted of 4 patients, with a mean age of 62.8 ± 20.3 years, who presented to our rheumatology unit between December 2012 and March 2018. Two patients were initially diagnosed with polyarthritis. One of these patients was eventually diagnosed with multiple myeloma and amyloidosis and the other was diagnosed with angioimmunoblastic T-cell lymphoma. The third patient was initially diagnosed with migratory arthritis and was eventually diagnosed with acute myeloid leukemia. The fourth patient was initially diagnosed with giant cell arteritis and eventually diagnosed with anaplastic large T-cell lymphoma. All the patients displayed a very good response to corticosteroid treatment. Vigilance for occult malignancy is essential in the diagnostic workup of RS. A good response to corticosteroids may constitute a major diagnostic pitfall in patients with hematological malignancies presenting with an apparent RS. In these cases, subtle clinical and laboratory features should elicit the clinician to seek for an occult malignancy.
众所周知,一些风湿综合征(RS)与几种血液系统恶性肿瘤有关。我们旨在描述模仿 RS 的血液系统恶性肿瘤患者的临床过程。我们研究了一系列最终诊断为血液系统恶性肿瘤的 4 名表现出明显 RS 的患者,并复习了相关文献。我们的系列包括 4 名患者,平均年龄为 62.8±20.3 岁,于 2012 年 12 月至 2018 年 3 月在我们的风湿病科就诊。2 名患者最初被诊断为多关节炎。其中 1 名患者最终被诊断为多发性骨髓瘤和淀粉样变性,另 1 名被诊断为血管免疫母细胞性 T 细胞淋巴瘤。第 3 名患者最初被诊断为游走性关节炎,最终被诊断为急性髓细胞白血病。第 4 名患者最初被诊断为巨细胞动脉炎,最终被诊断为间变性大细胞淋巴瘤。所有患者对皮质类固醇治疗均有很好的反应。在 RS 的诊断中,对隐匿性恶性肿瘤的警惕性至关重要。在表现出明显 RS 的血液系统恶性肿瘤患者中,皮质类固醇的良好反应可能构成主要的诊断陷阱。在这些情况下,细微的临床和实验室特征应促使临床医生寻找隐匿性恶性肿瘤。